Payments are transmitted through TransactRx from the patient’s pharmacy plan and are providers are reimbursed twice a month for submitted claims.
Coral Gables FL (PRWEB) May 29, 2013
TransactRx the nation’s leading Medicare Part D Vaccine Physician Billing System announced today that it has released Part 4 – Physician Office Medicare Part D Reimbursement for Vaccines of its 5-part education series titled “Running a Profitable Adult Vaccine Program in Your Practice”. The company will be publishing a new part each week of the series through June 2th on its new blog site http://www.transactrx.com/medical-blog.
In this week’s blog post TransactRx continues to dispel the misinformation in the marketplace that physician practices cannot be reimbursed for administering vaccines to Medicare Part D patients. Over the past 5 years TransactRx has helped over 10,000 physician practices and other medical facilities to implement the tools necessary to submit claims and receive Medicare Part D reimbursement for vaccines.
The TransactRx Part D Vaccine Manager provides all the online medical billing tools necessary to determine if a patient has Part D coverage, who the coverage is with, what the patient’s financial responsibility is for a particular vaccine and submit a claim in real-time to the patient’s pharmacy benefit manager. Payments are transmitted through TransactRx from the patient’s pharmacy plan and are providers are reimbursed twice a month for submitted claims.
TransactRx is on a mission to inform physicians and other healthcare providers “Vaccines are Good Medicine and Good Business.”
POC Network Technologies, Inc. d.b.a. TransactRx is a national provider of reimbursement solutions for vaccines and specialty pharmaceutical products administered at the point-of-care. The TransactRx proprietary cross-benefit technology platform seamlessly connects the nation’s pharmacy and medical transaction infrastructures to enable physicians, public health departments and pharmacies to check coverage information and submit claims for both medical and pharmacy benefits. The Company’s unique national provider networks significantly reduce the cost and effort associated with contracting a large numbers of providers to administer a particular vaccine or group of pharmaceutical products. The combination of technology and provider networks assists payers of all types.